Abstract
Cigarette smoke, a toxic collection of more than 4000 chemicals generated from combustion of tobacco plant leaves, is known to cause several respiratory ailments, including chronic bronchitis, emphysema and lung cancer, and is associated with an increase in respiratory infections. In addition, cigarette smoking is considered a principal aetiological factor responsible for the development of certain diffuse interstitial and bronchiolar lung diseases, namely respiratory bronchiolitis-interstitial lung disease (RB-ILD), desquamative interstitial pneumonia (DIP) and adult pulmonary Langerhans’ cell histiocytosis (PLCH). Although not exclusively seen in cigarette smokers, substantial clinical and epidemiological data support a central role for smoking as the primary causative agent of most RB-ILD, DIP and PLCH. Additional evidence in support of cigarette smoke as a primary aetiological agent in RB-ILD, DIP and PLCH is the observation that smoking cessation may lead to disease improvement, while recurrence of these disorders has been observed to occur in the transplanted lung upon re-exposure to tobacco smoke. Furthermore, histopathological changes of respiratory bronchiolitis, DIP and PLCH (with or without co-existent emphysema) may be found on lung biopsy in the same individual, implicating smoking as a common inciting agent of these diverse lesions. Recent studies also suggest a role for cigarette smoking as a potential co-factor in the development of acute eosinophilic pneumonia, usual interstitial pneumonia and rheumatoid arthritis-associated interstitial lung disease. In the current review, we propose a novel classification that takes into account the complex relationship between cigarette smoking and diffuse lung diseases. Investigation on the role of smoking as a potential causative factor or modifier of these diverse diffuse lung diseases is important, as smoking cessation utilizing state-of-the-art tobacco cessation efforts should be a central part of therapy, while pharmacotherapy with corticosteroids or other immune modifying agents should be reserved for selected patients.
Similar content being viewed by others
References|
Fraig M, Shreesha U, Savici D, et al. Respiratory bronchiolitis: a clinicopathologic study in current smokers, ex-smokers, and never-smokers. Am J Surg Pathol 2002 May; 26(5): 647–53
Friedman PJ, Liebow AA, Sokoloff J. Eosinophilic granuloma of lung: clinical aspects of primary histiocytosis in the adult. Medicine (Baltimore) 1981 Nov; 60(6): 385–96
Moon J, du Bois RM, Colby TV, et al. Clinical significance of respiratory bronchiolitis on open lung biopsy and its relationship to smoking related interstitial lung disease. Thorax 1999 Nov; 54(11): 1009–14
Myers JL, Veal Jr CF, Shin MS, et al. Respiratory bronchiolitis causing interstitial lung disease: a clinicopathologic study of six cases. Am Rev Respir Dis 1987 Apr; 135(4): 880–4
Ryu JH, Myers JL, Capizzi SA, et al. Desquamative interstitial pneumonia and respiratory bronchiolitis-associated interstitial lung disease. Chest 2005 Jan; 127(1): 178–84
Vassallo R, Ryu JH, Schroeder DR, et al. Clinical outcomes of pulmonary Langerhans’ cell histiocytosis in adults. N Engl J Med 2002 Feb 14; 346(7): 484–90
Caminati A, Harari S. Smoking-related interstitial pneumonias and pulmonary Langerhans cell histiocytosis. Proc Am Thorac Soc 2006 Jun; 3(4): 299–306
Miyake Y, Sasaki S, Yokoyama T, et al. Occupational and environmental factors and idiopathic pulmonary fibrosis in Japan. Ann Occup Hyg 2005 Apr; 49(3): 259–65
Baumgartner KB, Samet JM, Stidley CA, et al. Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1997; 155(1): 242–8
Nakajima M, Matsushima T. Acute eosinophilic pneumonia following cigarette smoking. Intern Med 2000 Oct; 39(10): 759–60
Watanabe K, Fujimura M, Kasahara K, et al. Acute eosinophilic pneumonia following cigarette smoking: a case report including cigarette-smoking challenge test. Intern Med 2002 Nov; 41(11): 1016–20
Kitahara Y, Matsumoto K, Taooka Y, et al. Cigarette smokinginduced acute eosinophilic pneumonia showing tolerance in broncho-alveolar lavage findings. Intern Med 2003 Oct; 42(10): 1016–21
Shorr AF, Scoville SL, Cersovsky SB, et al. Acute eosinophilic pneumonia among US Military personnel deployed in or near Iraq. JAMA 2004; 292(24): 2997–3005
Girard M, Israel-Assayag E, Cormier Y. Pathogenesis of hypersensitivity pneumonitis. Curr Opin Allergy Clin Immunol 2004 Apr; 4(2): 93–8
Vassallo R, Jensen EA, Colby TV, et al. The overlap between respiratory bronchiolitis and desquamative interstitial pneumonia in pulmonary Langerhans cell histiocytosis: high-resolution CT, histologic, and functional correlations. Chest 2003 Oct; 124(4): 1199–205
Travis WD, Borok Z, Roum JH, et al. Pulmonary Langerhans cell granulomatosis (histiocytosis X): a clinicopathologic study of 48 cases. Am J Surg Pathol 1993 Oct; 17(10): 971–86
Shiota Y, Kawai T, Matsumoto H, et al. Acute eosinophilic pneumonia following cigarette smoking. Intern Med 2000 Oct; 39(10): 830–3
Al-Saieg N, Moammar O, Kartan R. Flavored cigar smoking induces acute eosinophilic pneumonia. Chest 2007 Apr; 131(4): 1234–7
Miki K, Miki M, Okano Y, et al. Cigarette smoke-induced acute eosinophilic pneumonia accompanied with neutrophilia in the blood. Intern Med 2002 Nov; 41(11): 993–6
Donaghy M, Rees AJ. Cigarette smoking and lung haemorrhage in glomerulonephritis caused by autoantibodies to glomerular basement membrane. Lancet 1983 Dec 17; II(8364): 1390–3
Saag KG, Kolluri S, Koehnke RK, et al. Rheumatoid arthritis lung disease: determinants of radiographic and physiologic abnormalities. Arthritis Rheum 1996 Oct; 39(10): 1711–9
Wolfe F. The effect of smoking on clinical, laboratory, and radiographie status in rheumatoid arthritis. J Rheumatol 2000 Mar; 27(3): 630–7
Peros-Golubicic T, Ljubic S. Cigarette smoking and sarcoidosis. Acta Med Croatica 1995; 49(4-5): 187–93
Israel-Assayag E, Dakhama A, Lavigne S, et al. Expression of costimulatory molecules on alveolar macrophages in hypersensitivity pneumonitis. Am J Respir Crit Care Med 1999 Jun; 159(6): 1830–4
Colby TV, Lombard C. Histiocytosis X in the lung. Human Pathol 1983 Oct; 14(10): 847–56
Yousem SA, Colby TV, Gaensler EA. Respiratory bronchiolitis-associated interstitial lung disease and its relationship to desquamative interstitial pneumonia. Mayo Clin Proc 1989 Nov; 64(11): 1373–80
Delobbe A, Durieu J, Duhamel A, et al. Determinants of survival in pulmonary Langerhans’ cell granulomatosis (histiocytosis X). Groupe d’Etude en Pathologie Interstitielle de la Societe de Pathologie Thoracique du Nord. Eur Respir J 1996 Oct; 9(10): 2002–6
Craig PJ, Wells AU, Doffman S, et al. Desquamative interstitial pneumonia, respiratory bronchiolitis and their relationship to smoking. Histopathology 2004 Sep; 45(3): 275–82
Nakajima M, Manabe T, Niki Y, et al. A case of cigarette smoking-induced acute eosinophilic pneumonia showing tolerance. Chest 2000 Nov; 118(5): 1517–8
Luukkainen R, Saltyshev M, Pakkasela R, et al. Relationship of rheumatoid factor to lung diffusion capacity in smoking and non-smoking patients with rheumatoid arthritis. Scand Rheumatol 1995; 24(2): 119–20
Valeyre D, Soler P, Clerici C, et al. Smoking and pulmonary sarcoidosis: effect of cigarette smoking on prevalence, clinical manifestations, alveolitis, and evolution of the disease. Thorax 1988 Jul; 43(7): 516–24
Hance AJ, Basset F, Saumon G, et al. Smoking and interstitial lung disease. The effect of cigarette smoking on the incidence of pulmonary histiocytosis X and sarcoidosis. Ann N Y Acad Sci 1986; 465: 643–56
Warren CP. Extrinsic allergic alveolitis: a disease commoner in non-smokers. Thorax 1977 Oct; 32(5): 567–9
Douglas JG, Middleton WG, Gaddie J, et al. Sarcoidosis: a disorder commoner in non-smokers? Thorax 1986 Oct; 41(10): 787–91
Etienne B, Bertocchi M, Gamondes JP, et al. Relapsing pulmonary Langerhans cell histiocytosis after lung transplantation. Am J Respir Crit Care Med 1998 Jan; 157(1): 288–91
Mogulkoc N, Veral A, Bishop PW, et al. Pulmonary Langerhans’ cell histiocytosis: radiologie resolution following smoking cessation. Chest 1999 May; 115(5): 1452–5
Portnoy J, Veraldi KL, Schwarz MI, et al. Respiratory bronchiolitis-interstitial lung disease: long-term outcome. Chest 2007 Mar; 131(3): 664–71
Abbott GF, Rosado-de-Christenson ML, Franks TJ, et al. From the archives of the AFIP: pulmonary Langerhans cell histiocytosis. Radiographies 2004 May–Jun; 24(3): 821–41
Dauriat G, Mal H, Thabut G, et al. Lung transplantation for pulmonary Langerhans’ cell histiocytosis: a multicenter analysis. Transplantation 2006 Mar 15; 81(5): 746–50
Bernstrand C, Cederlund K, Ashtrom L, et al. Smoking preceded pulmonary involvement in adults with Langerhans cell histiocytosis diagnosed in childhood. Acta Paediatr 2000 Nov; 89(11): 1389–92
Zeid NA, Muller HK. Tobacco smoke induced lung granulomas and tumors: association with pulmonary Langerhans cells. Pathology 1995 Jul; 27(3): 247–54
Alp H, Daum RS, Abrahams C, et al. Acute eosinophilic pneumonia: a cause of reversible, severe, noninfectious respiratory failure. J Pediatr 1998 Mar; 132 (3 Pt 1): 540–3
Nakagome K, Kato J, Kubota S, et al. Acute eosinophilic pneumonia induced by cigarette smoking [in Japanese]. Nihon Kokyuki Gakkai Zasshi 2000 Feb; 38(2): 113–6
Klareskog L, Stolt P, Lundberg K, et al. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLADR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum 2006 Jan; 54(1): 38–46
Vassallo R, Tamada K, Lau JS, et al. Cigarette smoke extract suppresses human dendritic cell function leading to preferential induction of Th-2 priming. J Immunol 2005 Aug 15; 175(4): 2684–91
Cormier Y, Belanger J, Durand P. Factors influencing the development of serum precipitins to farmer’s lung antigen in Quebec dairy farmers. Thorax 1985 Feb; 40(2): 138–42
Hakala M, Paakko P, Huhti E, et al. Open lung biopsy of patients with rheumatoid arthritis. Clin Rheumatol 1990 Dec; 9(4): 452–60
Churg A, Muller NL, Flint J, et al. Chronic hypersensitivity pneumonitis. Am J Surg Pathol 2006 Feb; 30(2): 201–8
Ranney L, Melvin C, Lux L, et al. Systematic review: smoking cessation intervention strategies for adults and adults in special populations. Ann Intern Med 2006 Dec 5; 145(11): 845–56
Lancaster T, Stead L, Silagy C, et al. Effectiveness of interventions to help people stop smoking: findings from the Cochrane Library. BMJ 2000 Aug 5; 321(7257): 355–8
Molyneux A. Nicotine replacement therapy. BMJ 2004 Feb 21; 328(7437): 454–6
Silagy C, Lancaster T, Stead L, et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2004; (3): CD000146
Hurt RD, Sachs DP, Glover ED, et al. A comparison of sustained-release bupropion and placebo for smoking cessation. N Engl J Med 1997 Oct 23; 337(17): 1195–202
Jorenby DE, Hays JT, Rigotti NA, et al. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. JAMA 2006 Jul 5; 296(1): 56–63
Kuschner WG, D’Alessandro A, Wong H, et al. Dose-dependent cigarette smoking-related inflammatory responses in healthy adults. Eur Respir J 1996 Oct; 9(10): 1989–94
Casolaro MA, Bernaudin JF, Saltini C, et al. Accumulation of Langerhans’ cells on the epithelial surface of the lower respiratory tract in normal subjects in association with cigarette smoking. Am Rev Respir Dis 1988 Feb; 137(2): 406–11
Remy-Jardin M, Remy J, Gosselin B, et al. Lung parenchymal changes secondary to cigarette smoking: pathologic-CT correlations. Radiology 1993 Mar; 186(3): 643–51
Tomita K, Caramori G, Lim S, et al. Increased p21(CIPl/ WAF1) and B cell lymphoma leukemia-x(L) expression and reduced apoptosis in alveolar macrophages from smokers. Am J Respir Crit Care Med 2002 Sep 1; 166(5): 724–31
Tazi A, Bonay M, Bergeron A, et al. Role of granulocytemacrophage colony stimulating factor (GM-CSF) in the pathogenesis of adult pulmonary histiocytosis X. Thorax 1996 Jun; 51(6): 611–4
Tazi A, Bouchonnet F, Grandsaigne M, et al. Evidence that granulocyte macrophage-colony-stimulating factor regulates the distribution and differentiated state of dendritic cells/ Langerhans cells in human lung and lung cancers. J Clin Invest 1993 Feb; 91(2): 566–76
Wang RD, Wright JL, Churg A. Transforming growth factorbetal drives airway remodeling in cigarette smoke-exposed tracheal explants. Am J Respir Cell Mol Biol 2005 Oct; 33(4): 387–93
D’Hulst AI, Vermaelen KY, Brusselle GG, et al. Time course of cigarette smoke-induced pulmonary inflammation in mice. Eur Respir J 2005 Aug; 26(2): 204–13
Lu LM, Zavitz CC, Chen B, et al. Cigarette smoke impairs NK cell-dependent tumor immune surveillance. J Immunol 2007 Jan 15; 178(2): 936–43
Kode A, Yang SR, Rahman I. Differential effects of cigarette smoke on oxidative stress and proinflammatory cytokine release in primary human airway epithelial cells and in a variety of transformed alveolar epithelial cells. Respir Res 2006; 7: 132
Yang SR, Chida AS, Bauter MR, et al. Cigarette smoke induces proinflammatory cytokine release by activation of NF-kappaB and posttranslational modifications of histone deacetylase in macrophages. Am J Physiol 2006 Jul; 291(1): L46–57
Niewoehner DE, Kleinerman J, Rice DB. Pathologic changes in the peripheral airways of young cigarette smokers. N Engl J Med 1974 Oct 10; 291(15): 755–8
Ryu JH, Colby TV, Hartman TE, et al. Smoking-related interstitial lung diseases: a concise review. Eur Respir J 2001 Jan; 17(1): 122–32
Mavridou D, Laws D. Respiratory bronchiolitis associated interstitial lung disease (RB-ILD): a case of an acute presentation. Thorax 2004 Oct; 59(10): 910–1
Hartman TE, Tazelaar HD, Swensen SJ, et al. Cigarette smoking: CT and pathologic findings of associated pulmonary diseases. Radiographics 1997 Mar–Apr; 17(2): 377–90
Aubry MC, Wright JL, Myers JL. The pathology of smokingrelated lung diseases. Clin Chest Med 2000 Mar; 21(1): 11–35,vii
Wells AU, Nicholson AG, Hansell DM, et al. Respiratory bronchiolitis-associated interstitial lung disease. Semin Respir Crit Care Med 2003 Oct; 24(5): 585–94
Liebow AA, Steer A, Billingsley JG. Desquamative interstitial pneumonia. Am J Med 1965 Sep; 39: 369–404
Iskandar SB, McKinney LA, Shah L, et al. Desquamative interstitial pneumonia and hepatitis C virus infection: a rare association. South Med J 2004 Sep; 97(9): 890–3
Flores-Franco RA, Luevano-Flores E, Gaston-Ramirez C. Sirolimus-associated desquamative interstitial pneumonia. Respiration 2007; 74(2): 237–8
Hansell DM, Nicholson AG. Smoking-related diffuse parenchymal lung disease: HRCT-pathologic correlation. Semin Respir Crit Care Med 2003 Aug; 24(4): 377–92
Heyneman LE, Ward S, Lynch DA, et al. Respiratory bronchiolitis, respiratory bronchiolitis-associated interstitial lung disease, and desquamative interstitial pneumonia: different entities or part of the spectrum of the same disease process? Am J Roentgenol 1999 Dec; 173(6): 1617–22
Mueller-Mang C, Grosse C, Schmid K, et al. What every radiologist should know about idiopathic interstitial pneumonias. Radiographics 2007 May–Jun; 27(3): 595–615
Nagai S, Hoshino Y, Hayashi M, et al. Smoking-related interstitial lung diseases. Curr Opin Pulm Med 2000 Sep; 6(5): 415–9
Matsuo K, Tada S, Kataoka M, et al. Spontaneous remission of desquamative interstitial pneumonia. Intern Med 1997 Oct; 36(10): 728–31
Patchefsky AS, Fraimow W, Hoch WS. Desquamative interstitial pneumonia. Pathological findings and follow-up in 13 patients. Arch Intern Med 1973 Aug; 132(2): 222–5
Flusser G, Gurman G, Zirkin H, et al. Desquamative interstitial pneumonitis causing acute respiratory failure, responsive only to immunosuppressants. Respiration 1991; 58(5-6): 324–6
Verleden GM, Sels F, Van Raemdonck D, et al. Possible recurrence of desquamative interstitial pneumonitis in a single lung transplant recipient. Eur Respir J 1998 Apr; 11(4): 971–4
Vassallo R, Ryu JH, Colby TV, et al. Pulmonary Langerhans’ cell histiocytosis. N Engl J Med 2000 Jun 29; 342(26): 1969–78
Tazi A. Adult pulmonary Langerhans’ cell histiocytosis. Eur Respir J 2006 Jun; 27(6): 1272–85
Yousem SA, Colby TV, Chen YY, et al. Pulmonary Langerhans’ cell histiocytosis: molecular analysis of clonality. Am J Surg Pathol 2001 May; 25(5): 630–6
Favara BE, Feller AC, Pauli M, et al. Contemporary classification of histiocytic disorders. The WHO Committee On Histiocytic/ Reticulum Cell Proliferations. Reclassification Working Group of the Histiocyte Society. Med Pediatr Oncol 1997 Sep; 29(3): 157–66
Vassallo R, Ryu JH. Pulmonary Langerhans’ cell histiocytosis. Clin Chest Med 2004 Sep; 25(3): 561–71, vii
Arnett NL, Schulz DM. Primary pulmonary eosinophilic granuloma. Radiology 1957 Aug; 69(2): 224–30
Lewis JG. Eosinophilic granuloma and its variants with special reference to lung involvement, a report of 12 patients. Q J Med 1964 Jul; 33: 337–59
Lewis JG. Pulmonary manifestations of histiocytosis X. Proc R Soc Med 1971 Apr; 64(4): 338–40
Smith M, McCormack LJ, Van Ordstrand HS, et al. “Primary” pulmonary histiocytosis X. Chest 1974 Feb; 65(2): 176–80
Chaowalit N, Pellikka PA, Decker PA, et al. Echocardiographic and clinical characteristics of pulmonary hypertension complicating pulmonary Langerhans cell histiocytosis. Mayo Clin Proc 2004; 79(10): 1269–75
Aguayo SM, King Jr TE, Waldron Jr JA, et al. Increased pulmonary neuroendocrine cells with bombesin-like immunoreactivity in adult patients with eosinophilic granuloma. J Clin Invest 1990 Sep; 86(3): 838–44
Asakura S, Colby TV, Limper AH. Tissue localization of transforming growth factor-betal in pulmonary eosinophilic granuloma. Am J Respir Crit Care Med 1996 Nov; 154(5): 1525–30
Mendez JL, Nadrous HF, Vassallo R, et al. Pneumothorax in pulmonary Langerhans cell histiocytosis. Chest 2004 Mar; 125(3): 1028–32
Crausman RS, Jennings CA, Tuder RM, et al. Pulmonary histiocytosis X: pulmonary function and exercise pathophysiology. Am J Respir Crit Care Med 1996 Jan; 153(1): 426–35
Moore AD, Godwin JD, Muller NL, et al. Pulmonary histiocytosis X: comparison of radiographic and CT findings. Radiology 1989 Jul; 172(1): 249–54
Brauner MW, Grenier P, Mouelhi MM, et al. Pulmonary histiocytosis X: evaluation with high-resolution CT. Radiology 1989 Jul; 172(1): 255–8
Brauner MW, Grenier P, Tijani K, et al. Pulmonary Langerhans cell histiocytosis: evolution of lesions on CT scans. Radiology 1997 Aug; 204(2): 497–502
Soler P, Chollet S, Jacque C, et al. Immunocytochemical characterization of pulmonary histiocytosis X cells in lung biopsies. Am J Pathol 1985 Mar; 118(3): 439–51
Chollet S, Soler P, Bernaudin JF, et al. Exploratory bronchoalveolar lavage [in French]. Presse Med 1984 Jun 9; 13(24): 1503–8
Chollet S, Soler P, Dournovo P, et al. Diagnosis of pulmonary histiocytosis X by immunodetection of Langerhans cells in bronchoalveolar lavage fluid. Am J Pathol 1984 May; 115(2): 225–32
Fartoukh M, Humbert M, Capron F, et al. Severe pulmonary hypertension in histiocytosis X. Am J Respir Crit Care Med 2000 Jan; 161(1): 216–23
Negrin-Dastis S, Butenda D, Dorzee J, et al. Complete disappearance of lung abnormalities on high-resolution computed tomography: a case of histiocytosis X. Can Respir J 2007 May–Jun; 14(4): 235–7
Aerni MR, Aubry MC, Myers JL, et al. Complete remission of nodular pulmonary Langerhans cell histiocytosis lesions induced by 2-chlorodeoxyadenosine in a non-smoker. Respir Med 2008 Feb; 102(2): 316–9
Pardanani A, Phyliky RL, Li CY, et al. 2-Chlorodeoxyadenosine therapy for disseminated Langerhans cell histiocytosis. Mayo Clin Proc 2003 Mar; 78(3): 301–6
Saleem I, Moss J, Egan JJ. Lung transplantation for rare pulmonary diseases. Sarcoidosis Vasc Diffuse Lung Dis 2005 Dec; 22 Suppl. 1: S85–90
Yokoyama A, Mizushima Y, Suzuki H, et al. Acute eosinophilic pneumonia induced by minocycline: prominent Kerley B lines as a feature of positive re-challenge test. Jpn J Med 1990 Mar–Apr; 29(2): 195–8
Barnes MT, Bascunana J, Garcia B, et al. Acute eosinophilic pneumonia associated with antidepressant agents. Pharm World Sci 1999 Oct; 21(5): 241–2
Noh H, Lee YK, Kan SW, et al. Acute eosinophilic pneumonia associated with amitriptyline in a hemodialysis patient. Yonsei Med J 2001 Jun; 42(3): 357–9
McCormick M, Nelson T. Cocaine-induced fatal acute eosinophilic pneumonia: a case report. WMJ 2007 Apr; 106(2): 92–5
Rom WN, Weiden M, Garcia R, et al. Acute eosinophilic pneumonia in a New York City firefighter exposed to World Trade Center dust. Am J Respir Crit Care Med 2002 Sep 15; 166(6): 797–800
Takizawa H. Acute eosinophilic pneumonia: possible role of hyperreactivity of airway epithelial cells. Intern Med 2002 Nov; 41(11): 917
Glazer CS, Cohen LB, Schwarz MI. Acute eosinophilic pneumonia in AIDS. Chest 2001 Nov; 120(5): 1732–5
Hirai K, Yamazaki Y, Okada K, et al. Acute eosinophilic pneumonia associated with smoke from fireworks. Intern Med 2000 May; 39(5): 401–3
Johkoh T, Muller NL, Akira M, et al. Eosinophilic lung diseases: diagnostic accuracy of thin-section CT in 111 patients. Radiology 2000 Sep; 216(3): 773–80
Allen J. Acute eosinophilic pneumonia. Semin Respir Crit Care Med 2006 Apr; 27(2): 142–7
Fujimura M, Yasui M, Shinagawa S, et al. Bronchoalveolar lavage cell findings in three types of eosinophilic pneumonia: acute, chronic and drug-induced eosinophilic pneumonia. Respir Med 1998 May; 92(5): 743–9
Oshikawa K, Kuroiwa K, Tokunaga T, et al. Acute eosinophilic pneumonia with increased soluble ST2 in serum and bronchoalveolar lavage fluid. Respir Med 2001 Jun; 95(6): 532–3
Daimon T, Tajima S, Oshikawa K, et al. KL-6 and surfactant proteins A and D in serum and bronchoalveolar lavage fluid in patients with acute eosinophilic pneumonia. Intern Med 2005 Aug; 44(8): 811–7
Jeong YJ, Kim KI, Seo IJ, et al. Eosinophilic lung diseases: a clinical, radiologic, and pathologic overview. Radiographics 2007 May–Jun; 27(3): 617–37
Ricker DH, Taylor SR, Gartner Jr JC, et al. Fatal pulmonary aspergillosis presenting as acute eosinophilic pneumonia in a previously healthy child. Chest 1991 Sep; 100(3): 875–7
Buddharaju VL, Saraceno JL, Rosen JM, et al. Acute eosinophilic pneumonia associated with shock. Crit Care Med 1999 Sep; 27(9): 2014–6
Philit F, Etienne-Mastroianni B, Parrot A, et al. Idiopathic acute eosinophilic pneumonia: a study of 22 patients. Am J Respir Crit Care Med 2002 Nov 1; 166(9): 1235–9
Benz K, Amann K, Dittrich K, et al. Patient with antibodynegative relapse of Goodpasture syndrome. Clin Nephrol 2007 Apr; 67(4): 240–4
Flaherty KR, Martinez FJ. Cigarette smoking in interstitial lung disease: concepts for the internist. Med Clin North Am 2004 Nov; 88(6): 1643–53, xiii
King Jr TE, Tooze JA, Schwarz MI, et al. Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. Am J Respir Crit Care Med 2001; 164(7): 1171–81
Antoniou KM, Hansell DM, Rubens MB, et al. Idiopathic pulmonary fibrosis: outcome in relation to smoking status. Am J Respir Crit Care Med 2008 Jan 15; 177(2): 190–4
Arima K, Ando M, Ito K, et al. Effect of cigarette smoking on prevalence of summer-type hypersensitivity pneumonitis caused by Trichosporon cutaneum. Arch Environ Health 1992 Jul–Aug; 47(4): 274–8
Depierre A, Dalphin JC, Pernet D, et al. Epidemiological study of farmer’s lung in five districts of the French Doubs province. Thorax 1988 Jun; 43(6): 429–35
Chang JC, Distler SG, Kaplan AM. Tobacco smoke suppresses T cells but not antigen-presenting cells in the lung-associated lymph nodes. Toxicol Appl Pharmacol1990 Mar 1; 102(3): 514–23
Ohtsuka Y, Munakata M, Tanimura K, et al. Smoking promotes insidious and chronic farmer’s lung disease, and deteriorates the clinical outcome. Intern Med 1995 Oct; 34(10): 966–71
Newman LS, Rose CS, Bresnitz EA, et al. A case control etiologic study of sarcoidosis: environmental and occupational risk factors. Am J Respir Crit Care Med 2004 Dec 15; 170(12): 1324–30
Coates R, Neville E. The development of airways obstruction in sarcoidosis among smokers and non-smokers. Sarcoidosis 1993 Sep; 10(2): 115–7
den Boon S, van Lill SW, Borgdorff MW, et al. Association between smoking and tuberculosis infection: a population survey in a high tuberculosis incidence area. Thorax 2005 Jul; 60(7): 555–7
Ariyothai N, Podhipak A, Akarasewi P, et al. Cigarette smoking and its relation to pulmonary tuberculosis in adults. Southeast Asian J Trop Med Public Health 2004 Mar; 35(1): 219–27
Kolappan C, Gopi PG. Tobacco smoking and pulmonary tuberculosis. Thorax 2002 Nov; 57(11): 964–6
Guidon G, BoisclairD. Past, current and future trends in tobacco use. Health nutrition and population discussion paper, World Bank Human Development Network, 2003 [online]. Available from URL: http://siteresources.worldbank.org/HEALTHNUTRITIONANDPOPULATION/Resources/281627-1095698140167/Guindon-PastCurrent-whole.pdf [Accessed 2008 Jun18]
Acknowledgements
This work was supported by a Flight Attendant Medical Research Institute grant, an Annenberg Career Development Award and an American Histiocytosis Association award to Dr Robert Vassallo. The authors have no conflict of interest or any disclosures relevant to this publication. All authors have directly contributed to the content of this article and reviewed the final version.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Patel, R.R., Ryu, J.H. & Vassallo, R. Cigarette Smoking and Diffuse Lung Disease. Drugs 68, 1511–1527 (2008). https://doi.org/10.2165/00003495-200868110-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-200868110-00004